Ketorolac is a non-steroidal anti-inflammatory agent demonstrating analgesic and anti-inflammatory activity. Ketorolac inhibits the cyclo-oxygenase enzyme essential for biosynthesis of prostaglandins. Ketorolac has been shown to reduce prostaglandin levels in the aqueous humour after topical ophthalmic administration.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Ketorolac is the active ingredient of these drugs:
Austria Brazil Canada France Hong Kong
United States
Canada Singapore United States
Italy
Brazil
Brazil
Cyprus
Italy
Lithuania
Singapore
Lithuania
Austria
Hong Kong
Italy
Italy
Italy
Brazil
Brazil
United States
Brazil Canada Finland Hong Kong Italy
Brazil
Brazil
Ketorolac is also found within below combination drugs:
Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):